This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Clinical Trial of Ginseng in Diabetes

This study has been completed.
Sponsor:
Information provided by:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00781534
First received: October 27, 2008
Last updated: February 18, 2010
Last verified: February 2010
  Purpose
a clinical study of Ginseng its potential affect on diabetes

Condition Intervention Phase
Diabetes Dietary Supplement: Ginseng, ginsenoside Re or placebo Dietary Supplement: Ginseng Dietary Supplement: ginsenoside RE Dietary Supplement: Placebo (sugar pill) Early Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: A Clinical Trial of Ginseng for Glucose Intolerance

Further study details as provided by Washington University School of Medicine:

Enrollment: 19
Study Start Date: September 2003
Study Completion Date: September 2008
Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1. Ginseng
Ginseng group
Dietary Supplement: Ginseng, ginsenoside Re or placebo
Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups
Active Comparator: 2. Ginsenosdie RE
Ginsenoside RE (a metabolite of ginseng) group
Dietary Supplement: Ginseng Dietary Supplement: ginsenoside RE
active metabolite of ginseng
Placebo Comparator: 3. Placebo
placebo ("sugar" pill) group
Dietary Supplement: Placebo (sugar pill)

Detailed Description:

Comparing three groups (those with & without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking:

  1. ginseng
  2. ginsenoside RE (a type of metabolized ginseng)
  3. placebo
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • ages 18-65
  • healthy, non-diabetic
  • healthy, impaired glucose tolerance/mild diabetes (no medications required)

Exclusion Criteria:

  • impaired glucose tolerance (borderline diabetes that requires medications)
  • diabetes (requiring medications)
  • caffeine sensitivity
  • known cardiac, peripheral vascular diseases
  • arrhythmias (irregular heart rhythms)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00781534

Locations
United States, Missouri
Washington University School of Medicine
St. Louis, Missouri, United States, 63110
Sponsors and Collaborators
Washington University School of Medicine
Investigators
Principal Investigator: Kenneth S Polonsky, MD Washington University School of Medicine
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kenneth S. Polonsky, MD, Washington University School of Medicine
ClinicalTrials.gov Identifier: NCT00781534     History of Changes
Other Study ID Numbers: 03-0824
Study First Received: October 27, 2008
Last Updated: February 18, 2010

Keywords provided by Washington University School of Medicine:
Health Supplements
Ginseng
Diabetes

ClinicalTrials.gov processed this record on June 29, 2017